XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 42.34%5.23B | 42.34%5.23B | 39.01%4.56B | 28.85%4B | 33.17%3.87B | 39.51%3.67B | 39.51%3.67B | 33.01%3.28B | 26.27%3.1B | 15.17%2.9B |
-Cash and cash equivalents | 152.52%2.1B | 152.52%2.1B | -26.11%768.71M | -51.45%512.66M | -58.85%520.39M | -68.02%831.05M | -68.02%831.05M | -56.86%1.04B | -55.23%1.06B | -44.27%1.26B |
-Short-term investments | 10.14%3.13B | 10.14%3.13B | 69.22%3.8B | 70.26%3.49B | 104.14%3.35B | 7,992.02%2.84B | 7,992.02%2.84B | 3,812.08%2.24B | 1,963.63%2.05B | 549.26%1.64B |
Receivables | 57.64%575.05M | 57.64%575.05M | 55.28%668.11M | 75.47%659.34M | 91.70%486.99M | 41.20%364.78M | 41.20%364.78M | 25.35%430.27M | 41.35%375.76M | -0.98%254.04M |
-Accounts receivable | 57.64%575.05M | 57.64%575.05M | 55.28%668.11M | 75.47%659.34M | 91.70%486.99M | 41.20%364.78M | 41.20%364.78M | 25.35%430.27M | 41.35%375.76M | -0.98%254.04M |
Restricted cash | ---- | ---- | ---- | ---- | ---- | -97.72%370K | -97.72%370K | ---- | ---- | -64.66%11.95M |
Other current assets | 30.18%129.25M | 30.18%129.25M | 24.74%119.19M | 18.19%115.71M | -5.19%81.18M | -25.52%99.29M | -25.52%99.29M | -16.30%95.55M | -35.11%97.91M | -25.57%85.63M |
Total current assets | 43.39%5.93B | 43.39%5.93B | 40.49%5.35B | 33.45%4.77B | 36.24%4.44B | 36.07%4.14B | 36.07%4.14B | 29.28%3.81B | 23.24%3.58B | 11.23%3.26B |
Non current assets | ||||||||||
Net PPE | 4.23%240.38M | 4.23%240.38M | 4.82%251.92M | 1.25%256.94M | -19.23%220.61M | -14.40%230.62M | -14.40%230.62M | -6.55%240.32M | -2.04%253.76M | 2.39%273.13M |
-Gross PPE | -27.77%240.38M | -27.77%240.38M | 10.76%372M | 7.16%368.82M | -8.46%328.33M | -5.41%332.78M | -5.41%332.78M | 1.21%335.87M | 4.16%344.19M | 6.59%358.66M |
-Accumulated depreciation | ---- | ---- | -25.68%-120.09M | -23.73%-111.89M | -25.94%-107.72M | -23.96%-102.16M | -23.96%-102.16M | -27.95%-95.55M | -26.68%-90.43M | -22.63%-85.53M |
Other non current assets | 8.51%166.22M | 8.51%166.22M | 14.28%164.22M | 7.92%161.43M | -2.25%150.4M | 1.95%153.19M | 1.95%153.19M | 24.91%143.7M | 23.79%149.59M | 23.04%153.86M |
Total non current assets | 5.94%406.6M | 5.94%406.6M | 8.36%416.14M | 3.72%418.37M | -13.11%371.02M | -8.54%383.81M | -8.54%383.81M | 3.17%384.02M | 6.17%403.35M | 8.98%426.99M |
Total assets | 40.21%6.34B | 40.21%6.34B | 37.55%5.77B | 30.44%5.19B | 30.52%4.81B | 30.66%4.52B | 30.66%4.52B | 26.35%4.19B | 21.26%3.98B | 10.97%3.68B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -99.83%103K | -99.83%103K | 28.33%58.97M | 2,236.31%107.77M | 26.75%69.65M | -31.05%59.38M | -31.05%59.38M | -22.78%45.95M | -91.88%4.61M | 100.15%54.95M |
-accounts payable | -99.15%103K | -99.15%103K | 185.18%27.02M | 1,359.90%67.35M | 686.62%35.63M | -72.93%12.12M | -72.93%12.12M | -84.08%9.48M | -91.88%4.61M | -83.50%4.53M |
-Total tax payable | ---- | ---- | -12.41%31.95M | --40.43M | -32.54%34.01M | 14.35%47.26M | 14.35%47.26M | --36.48M | ---- | --50.42M |
Current accrued expenses | 143.01%427.05M | 143.01%427.05M | 68.72%233.29M | -16.01%155.06M | 38.61%172.02M | 33.75%175.73M | 33.75%175.73M | -16.04%138.27M | -1.57%184.62M | -17.36%124.11M |
Current debt and capital lease obligation | -18.80%43.99M | -18.80%43.99M | -8.75%47.64M | -14.91%44.13M | 1.87%54.06M | 20.13%54.18M | 20.13%54.18M | 29.75%52.2M | 26.76%51.86M | 32.52%53.07M |
-Current capital lease obligation | -18.80%43.99M | -18.80%43.99M | -8.75%47.64M | -14.91%44.13M | 1.87%54.06M | 20.13%54.18M | 20.13%54.18M | 29.75%52.2M | 26.76%51.86M | 32.52%53.07M |
Current deferred liabilities | 14.92%524.88M | 14.92%524.88M | 33.38%603.55M | 12.53%499.96M | 23.16%454.83M | 40.39%456.73M | 40.39%456.73M | 6.74%452.49M | 16.78%444.3M | -18.19%369.29M |
Current liabilities | 33.51%996.02M | 33.51%996.02M | 36.95%943.46M | 17.73%806.92M | 24.80%750.55M | 26.89%746.02M | 26.89%746.02M | 0.08%688.93M | 2.95%685.38M | -10.12%601.41M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 11.42%195.23M | 11.42%195.23M | 12.61%207.28M | 10.41%214.33M | -21.03%163.01M | -14.24%175.22M | -14.24%175.22M | -10.17%184.07M | -10.15%194.13M | -9.31%206.42M |
-Long term capital lease obligation | 11.42%195.23M | 11.42%195.23M | 12.61%207.28M | 10.41%214.33M | -21.03%163.01M | -14.24%175.22M | -14.24%175.22M | -10.17%184.07M | -10.15%194.13M | -9.31%206.42M |
Non current deferred liabilities | 40.73%41.55M | 40.73%41.55M | -69.00%11.51M | -67.90%17.18M | -61.80%22.37M | 112.39%29.52M | 112.39%29.52M | 0.54%37.11M | 7.97%53.51M | 5.48%58.56M |
Other non current liabilities | 27.87%13.69M | 27.87%13.69M | 26.99%14.5M | 29.29%15.65M | -26.42%9.97M | -15.43%10.7M | -15.43%10.7M | 456.51%11.41M | 460.75%12.1M | 518.07%13.55M |
Total non current liabilities | 16.25%250.46M | 16.25%250.46M | 0.29%233.28M | -4.85%247.16M | -29.86%195.35M | -6.68%215.44M | -6.68%215.44M | -4.62%232.6M | -3.00%259.74M | -2.38%278.53M |
Total liabilities | 29.64%1.25B | 29.64%1.25B | 27.70%1.18B | 11.53%1.05B | 7.50%945.91M | 17.42%961.46M | 17.42%961.46M | -1.15%921.52M | 1.24%945.13M | -7.80%879.95M |
Shareholders'equity | ||||||||||
Share capital | 6.32%2.34M | 6.32%2.34M | 4.42%2.27M | 4.14%2.24M | 5.20%2.23M | 4.81%2.2M | 4.81%2.2M | 4.52%2.17M | 4.17%2.15M | 3.47%2.12M |
-common stock | 6.32%2.34M | 6.32%2.34M | 4.42%2.27M | 4.14%2.24M | 5.20%2.23M | 4.81%2.2M | 4.81%2.2M | 4.52%2.17M | 4.17%2.15M | 3.47%2.12M |
Retained earnings | 8.18%-5.19B | 8.18%-5.19B | 8.30%-5.27B | 6.96%-5.41B | 5.11%-5.54B | 3.58%-5.65B | 3.58%-5.65B | 2.50%-5.74B | -0.83%-5.81B | -4.57%-5.84B |
Paid-in capital | 11.75%10.19B | 11.75%10.19B | 9.17%9.76B | 7.87%9.46B | 8.80%9.32B | 8.24%9.12B | 8.24%9.12B | 7.89%8.94B | 8.04%8.77B | 7.73%8.57B |
Gains losses not affecting retained earnings | -800.50%-5.61M | -800.50%-5.61M | 168.36%4.93M | 5.26%-4.94M | -32.47%-5.72M | 115.02%801K | 115.02%801K | 26.74%-7.21M | 21.95%-5.21M | -6.78%-4.32M |
Total stockholders'equity | 43.96%5B | 43.96%5B | 41.01%4.5B | 37.05%4.05B | 38.60%3.78B | 35.48%3.48B | 35.48%3.48B | 33.66%3.19B | 25.83%2.96B | 15.18%2.72B |
Noncontrolling interests | 6.71%91.13M | 6.71%91.13M | 13.85%93.22M | 9.56%87.28M | 8.16%85.95M | 10.75%85.4M | 10.75%85.4M | --81.88M | --79.66M | --79.46M |
Total equity | 43.06%5.09B | 43.06%5.09B | 40.33%4.59B | 36.33%4.14B | 37.74%3.86B | 34.76%3.56B | 34.76%3.56B | 37.09%3.27B | 29.22%3.04B | 18.54%2.8B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |